Adicet Bio Statistics
Total Valuation
Adicet Bio has a market cap or net worth of $60.77 million. The enterprise value is -$96.64 million.
Important Dates
The last earnings date was Thursday, March 6, 2025, after market close.
| Earnings Date | Mar 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Adicet Bio has 82.69 million shares outstanding. The number of shares has increased by 104.14% in one year.
| Current Share Class | 82.69M |
| Shares Outstanding | 82.69M |
| Shares Change (YoY) | +104.14% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 1.65% |
| Owned by Institutions (%) | 45.59% |
| Float | 61.37M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.33 |
| P/TBV Ratio | 0.33 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.29, with a Debt / Equity ratio of 0.09.
| Current Ratio | 9.29 |
| Quick Ratio | 9.09 |
| Debt / Equity | 0.09 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -31,903.75 |
Financial Efficiency
Return on equity (ROE) is -65.65% and return on invested capital (ROIC) is -40.39%.
| Return on Equity (ROE) | -65.65% |
| Return on Assets (ROA) | -37.31% |
| Return on Invested Capital (ROIC) | -40.39% |
| Return on Capital Employed (ROCE) | -63.54% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$770,539 |
| Employee Count | 152 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -68.72% in the last 52 weeks. The beta is 1.62, so Adicet Bio's price volatility has been higher than the market average.
| Beta (5Y) | 1.62 |
| 52-Week Price Change | -68.72% |
| 50-Day Moving Average | 0.88 |
| 200-Day Moving Average | 1.17 |
| Relative Strength Index (RSI) | 38.25 |
| Average Volume (20 Days) | 316,074 |
Short Selling Information
The latest short interest is 2.83 million, so 3.43% of the outstanding shares have been sold short.
| Short Interest | 2.83M |
| Short Previous Month | 3.14M |
| Short % of Shares Out | 3.43% |
| Short % of Float | 4.62% |
| Short Ratio (days to cover) | 6.39 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -127.62M |
| Pretax Income | -139.79M |
| Net Income | -117.12M |
| EBITDA | -121.15M |
| EBIT | -127.62M |
| Earnings Per Share (EPS) | -$1.33 |
Full Income StatementBalance Sheet
The company has $176.30 million in cash and $17.23 million in debt, giving a net cash position of $159.07 million or $1.92 per share.
| Cash & Cash Equivalents | 176.30M |
| Total Debt | 17.23M |
| Net Cash | 159.07M |
| Net Cash Per Share | $1.92 |
| Equity (Book Value) | 186.61M |
| Book Value Per Share | 2.26 |
| Working Capital | 160.74M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$92.38 million and capital expenditures -$1.12 million, giving a free cash flow of -$93.50 million.
| Operating Cash Flow | -92.38M |
| Capital Expenditures | -1.12M |
| Free Cash Flow | -93.50M |
| FCF Per Share | -$1.13 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |